Novel strategy to diagnose and grade hepatocellular carcinoma

Parveen, Shahida; Mehboob, Riffat; Aslam Khan, Asad; Hussain Bukhari, Mulazim; Jawad Ahmad, Fridoon
January 2013
Natural Science;Jan2013, Vol. 5 Issue 1, p22
Academic Journal
Hepatocellular carcinoma (HCC) is among the most common malignancies worldwide, particularly in South and South East Asia. Unfortunately due to lack of appropriate facilities and awareness only limited information is available about its early diagnosis. Aim of the present study was to determine the efficacy of p53 by immunohistochemistry and Argyrophilicnucleolar organizer regions (AgNORs) in diagnosis of HCC and cirrhosis of liver. A total of 100 liver biopsies were studied, it included 20 cases of HCC, 60 cases of cirrhosis of the liver and 20 cases of normal liver from autopsy specimens as a control. Out of 20 cases of HCC, 15 were positive for p53 stain and 5 were negative. None of the 60 cases of cirrhosis or 20 with normal histology revealed p53 expression. A statistically significant (p < 0.001) difference was observed between mean AgNOR counts of normal (1.57 +/- 0.13), cirrhotic (4.70 +/- 0.66) and HCC tissues (14.96 +/- 1.18). In contrast the mean AgNOR count of biopsies with alcoholic cirrhosis (1.57 +/- 1.62) was significantly less (p < 0.001) than post-hepatitic cirrhosis and was similar to that of normal liver tissue. AgNORs differentiates post-hepatitic and alcoholic cirrhosis. HCV and HBV were found to be the main causative agents in HCC and Cirrhosis of liver. Mean age of HCC patients was slightly higher than liver cirrhosis patients. It is concluded that p53 and AgNORs can act as a good adjuvant to histology in diagnosing liver diseases. It helps in differentiation from well differentiated to moderately and to poorly differentiated HCC.


Related Articles

  • CLONING OF MELANOMA ANTIGEN-1 (MAGE-1) GENE FROM FINE NEEDLE ASPIRATION BIOPSY OF HEPATIC TISSUE OF HEPATOCELLULER CARCINOMA PATIENTS. Mastutik, Gondo; I'tishom, Reny; Lunardi, J. H.; Puspaningsih, Ni Nyoman Tri; Kusumobroto, Hernomo Ontoseno; Putra, Suhartono Taat // Folia Medica Indonesiana;jul2010, Vol. 46 Issue 3, p200 

    Hepatocellular carcinoma (HCC) is one of the most common malignancies in Asia and it is generally diagnosed at advanced stage, during which the prognosis of the patients has been poor and their capability to survive has also been low. Hepatic tissue of HCC patients expresses mRNA of melanoma...

  • Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy. Feng Hua Wang; Yuk Ching Yip; Meng Zhang; Heong Ting Vong; Kin Iong Chan; Kit Cheng Wai; Jian Ming Wen // Journal of Clinical Pathology;Jul2010, Vol. 63 Issue 7, p6 

    Aims Glypican 3 (GPC3) is a heparan sulphate proteoglycan that shows elevated levels in the serum of patients with hepatocellular carcinoma (HCC), but not in healthy blood donors or patients with benign liver disease. This study explores the value of GPC3 expression for diagnosis of HCC by...

  • Low expression of GNAI3 predicts poor prognosis in patients with HCC. Guodong Chen; Xiaoyan Li; Gengsheng He; Zijian Yu; Jiaxing Luo; Jun He; Zonghai Huang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 11, p21482 

    Purposes: This study was performed with an aim to explain the underlying role of GNAI3 on the prognosis of patients with HCC. Methods: The expression of GNAI3 at protein level was detected with the utilization of Immunohistochemistry (IHC). Chi-square test was conducted to assay the relationship...

  • Liver Biopsy and Screening for Cancer in Hepatitis C. Gebo, Kelly A.; Bass, Eric B. // American Family Physician;11/1/2003, Vol. 68 Issue 9, p1719 

    Highlights two aspects of management that may not receive attention as the issue of treatment choice for hepatitis C. Assessment of the utility of liver biopsy in predicting treatment response; Incidence of hepatocellular carcinoma screening in patients with hepatitis C.

  • Staging laparoscopy in patients with hepatocellular carcinoma: is it useful? Hoekstra, Lisette; Bieze, Matthanja; Busch, Olivier; Gouma, Dirk; Gulik, Thomas // Surgical Endoscopy;Mar2013, Vol. 27 Issue 3, p826 

    Background: Staging laparoscopy (SL) is not regularly performed for patients with hepatocellular carcinoma (HCC). It may change treatment strategy, preventing unnecessary open exploration. An additional advantage of SL is possible biopsy of the nontumorous liver to assess fibrosis/cirrhosis....

  • Fine Needle Aspiration Cytology of Hepatocellular Carcinoma. Rasheed, Enas Abdulmajeed // Tikrit Medical Journal;2011, Vol. 17 Issue 2, p161 

    A prospective study of (13) patients, from both sex, with hepatocellular carcinoma was done in Salahuldeen government in Tikrit teaching hospital in period extent from Feb. 2006 to Aug. 2010. Patients divided into: 1-Those underwent FNAC for liver mass (5 patients) (38.5%), for diagnosis in...

  • Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma. Wang, Lijun; Wang, Jianguo; Zhang, Xuanyu; Li, Jie; Wei, Xuyong; Cheng, Jun; Ling, Qi; Xie, Haiyang; Zhou, Lin; Xu, Xiao; Zheng, Shusen // PLoS ONE;12/14/2015, Vol. 10 Issue 12, p1 

    Background: Needle core biopsy (NCB) is one of the most widely used and accepted methods for the diagnosis of focal hepatic lesions. Although many studies have assessed the diagnostic accuracy of NCB in predicting the tumor grade, it is still under debate. Objective: To identify the influence...

  • Evaluation of hepatocellular carcinoma angiogenesis before and after microwave ablation by real-time gray-scale contrast-enhanced ultrasound. Hua Wang; Wen Chu; Yuhong Kou; Weiwei Cai; Bin Li; Shouyan Zhang; Zhanhui Wang // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 7, p14430 

    This study aims to evaluate focal angiogenesis of hepatocellular carcinoma (HCC) before and after microwave ablation (MWA) by real-time gray-scale contrast-enhanced ultrasound (CEUS). One month before and after MWA, biopsy was performed in all 90 HCC patients. Immunohistochemistry was used to...

  • International pediatric liver cancer pathological classification: current trend. Tanaka, Yukichi; Inoue, Takeshi; Horie, Hiroshi // International Journal of Clinical Oncology;Dec2013, Vol. 18 Issue 6, p946 

    This review describes the pathological classification of pediatric liver cancer types and subtypes proposed at the recent international symposium (March 2011, Los Angeles, USA) and meetings involving pathologists serving as central reviewers for the Children's Oncology Group, Société...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics